Jyong Biotech Ltd.
MENS
$55.24
$1.182.18%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 98.00K | 98.00K | 96.00K | 96.00K | 177.00K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 105.00K | 105.00K | 101.00K | 101.00K | 97.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.00K | 3.00K | 3.00K | 3.00K | 1.57M |
| Total Current Assets | 206.00K | 206.00K | 200.00K | 200.00K | 1.84M |
|
|
|||||
| Total Current Assets | 206.00K | 206.00K | 200.00K | 200.00K | 1.84M |
| Net Property, Plant & Equipment | 3.19M | 3.19M | 3.34M | 3.34M | 3.54M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.97M | 2.97M | 2.90M | 2.90M | 2.87M |
| Total Assets | 6.37M | 6.37M | 6.44M | 6.44M | 8.25M |
|
|
|||||
| Total Accounts Payable | 3.00K | 3.00K | 9.00K | 9.00K | 2.00K |
| Total Accrued Expenses | 1.32M | 1.32M | 969.00K | 969.00K | 1.14M |
| Short-term Debt | 7.23M | 7.23M | 7.10M | 7.10M | 7.90M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 216.00K | 216.00K | 522.00K | 522.00K | 205.00K |
| Total Finance Division Other Current Liabilities | 3.37M | 3.37M | 3.33M | 3.33M | 5.02M |
| Total Other Current Liabilities | 3.37M | 3.37M | 3.33M | 3.33M | 5.02M |
| Total Current Liabilities | 12.13M | 12.13M | 11.93M | 11.93M | 14.26M |
|
|
|||||
| Total Current Liabilities | 12.13M | 12.13M | 11.93M | 11.93M | 14.26M |
| Long-Term Debt | 10.68M | 10.68M | 9.67M | 9.67M | 8.52M |
| Short-term Debt | 7.23M | 7.23M | 7.10M | 7.10M | 7.90M |
| Capital Leases | 16.00K | 16.00K | 77.00K | 77.00K | 69.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 20.06M | 20.06M | 19.69M | 19.69M | 19.47M |
| Total Liabilities | 42.89M | 42.89M | 41.37M | 41.37M | 42.32M |
|
|
|||||
| Common Stock & APIC | 11.81M | 11.81M | 11.81M | 11.81M | 11.81M |
| Retained Earnings | -33.08M | -33.08M | -31.39M | -31.39M | -30.06M |
| Treasury Stock & Other | -15.25M | -15.25M | -15.35M | -15.35M | -15.82M |
| Total Common Equity | -36.52M | -36.52M | -34.93M | -34.93M | -34.07M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -36.52M | -36.52M | -34.93M | -34.93M | -34.07M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -36.52M | -36.52M | -34.93M | -34.93M | -34.07M |
|
|
|||||